Clinical Trials Directory

Trials / Conditions / Stage IV Urethral Cancer AJCC v8

Stage IV Urethral Cancer AJCC v8

10 registered clinical trials studyying Stage IV Urethral Cancer AJCC v8 — 1 currently recruiting.

StatusTrialSponsorPhase
Active Not RecruitingTesting Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemo
NCT04963153
National Cancer Institute (NCI)Phase 1
Active Not RecruitingTesting the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in
NCT05092958
National Cancer Institute (NCI)Phase 3
Active Not RecruitingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or
NCT04940299
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingARID1A and/or KDM6A Mutation and CXCL13 Expression
NCT04953104
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingImmune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma
NCT04848519
Emory UniversityPhase 2
CompletedAtezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial C
NCT03513952
National Cancer Institute (NCI)Phase 2
RecruitingTesting the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted
NCT03866382
National Cancer Institute (NCI)Phase 2
Active Not RecruitingPembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small
NCT03582475
Jonsson Comprehensive Cancer CenterPhase 1
Active Not RecruitingAtezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metasta
NCT03237780
National Cancer Institute (NCI)Phase 2
Active Not RecruitingCabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourin
NCT02496208
National Cancer Institute (NCI)Phase 1